Ingrid Thörn

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Amini, Rose-Marie; Enblad, Gunilla; Hollander, Peter; Laszlo, S. et al.

Ingår i BMC Cancer, 2019

• DOI för Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
• Ladda ner fulltext (pdf) av Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Modvig, S; Madsen, H O; Siitonen, S M; Rosthøj, S et al.

Ingår i Leukemia, s. 1324-1336, 2019

• DOI för Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

Löf, Liza; Arngården, Linda; Olsson-Strömberg, Ulla; Siart, Benjamin et al.

Ingår i Scientific Reports, s. 1-9, 2017

• DOI för Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
• Ladda ner fulltext (pdf) av Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

The ETV6/RUNX1 fusion transcript is not detected in RNA isolated from neonatal dried blood spots from children later diagnosed with the corresponding leukemia

Barbany, Gisela; Gauffin, Fredrika; Ofverholm, Ingegerd; Karlsson, Hakan et al.

Ingår i Leukemia and Lymphoma, s. 2742-2744, 2013

• DOI för The ETV6/RUNX1 fusion transcript is not detected in RNA isolated from neonatal dried blood spots from children later diagnosed with the corresponding leukemia

In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia

Lönnerholm, Gudmar; Thörn, Ingrid; Sundström, Christer; Frost, Britt-Marie et al.

Ingår i Leukemia Research, s. 472-478, 2011

• DOI för In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Amini, Rose-Marie; Enblad, Gunilla; Hollander, Peter; Laszlo, S. et al.

Ingår i BMC Cancer, 2019

• DOI för Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
• Ladda ner fulltext (pdf) av Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Modvig, S; Madsen, H O; Siitonen, S M; Rosthøj, S et al.

Ingår i Leukemia, s. 1324-1336, 2019

• DOI för Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

Löf, Liza; Arngården, Linda; Olsson-Strömberg, Ulla; Siart, Benjamin et al.

Ingår i Scientific Reports, s. 1-9, 2017

• DOI för Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
• Ladda ner fulltext (pdf) av Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

The ETV6/RUNX1 fusion transcript is not detected in RNA isolated from neonatal dried blood spots from children later diagnosed with the corresponding leukemia

Barbany, Gisela; Gauffin, Fredrika; Ofverholm, Ingegerd; Karlsson, Hakan et al.

Ingår i Leukemia and Lymphoma, s. 2742-2744, 2013

• DOI för The ETV6/RUNX1 fusion transcript is not detected in RNA isolated from neonatal dried blood spots from children later diagnosed with the corresponding leukemia

In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia

Lönnerholm, Gudmar; Thörn, Ingrid; Sundström, Christer; Frost, Britt-Marie et al.

Ingår i Leukemia Research, s. 472-478, 2011

• DOI för In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia

Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.

Thörn, Ingrid; Forestier, Erik; Botling, Johan; Thuresson, Britt et al.

Ingår i British Journal of Haematology, s. 743-753, 2011

• DOI för Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.

Both CD4(+) FoxP3(+) and CD4(+) FoxP3(-) T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Lindqvist, Camilla; Christiansson, Lisa; Thörn, Ingrid; Mangsbo, Sara et al.

Ingår i Immunology, s. 296-306, 2011

• DOI för Both CD4(+) FoxP3(+) and CD4(+) FoxP3(-) T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006

Thörn, Ingrid; Forestier, Erik; Thuresson, Britt; Wasslavik, Carina et al.

Ingår i European Journal of Haematology, s. 117-127, 2010

• DOI för Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006

Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia

Thörn, Ingrid; Botling, Johan; Hermansson, Monica; Lönnerholm, Gudmar et al.

Ingår i Leukemia Research, s. 1047-1054, 2009

• DOI för Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia

In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia

Lönnerholm, Gudmar; Thörn, Ingrid; Sundström, Christer; Frost, Britt-Marie et al.

Ingår i Leukemia Research, s. 46-53, 2009

• DOI för In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia

U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner

Boström, Hans; Leuchowius, Karl-Johan; Hallböök, Helene; Nordgren, Ann et al.

Ingår i European Journal of Haematology, s. 218-225, 2008

• DOI för U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

Tobin, Gerard; Thunberg, Ulf; Johnson, Anna; Thörn, Ingrid et al.

Ingår i Blood, s. 2262-2264, 2002

Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukemia

Thörn, Ingrid

2009

• Ladda ner fulltext (pdf) av Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukemia

Analysis of IG/TCR gene rearrangements in Swedish childhood acute lymphoblastic leukemia diagnosed 2002-2006: a multi-centre study supporting the applicability of real-time-PCR for minimal residual disease assessment

Thörn, Ingrid; Forestier, Erik; Thuresson, Britt; Wasslavik, Carina et al.

Minimal residual disease assessment in childhood acute lymphoblastic leukemia: Results of a Swedish multi-centre study comparing real-time PCR and multi-colour flow cytometry

Thörn, Ingrid; Forestier, Erik; Botling, Johan; Thuresson, Britt et al.

2009